Indication
Pancreatic neuroendocrine tumor
A pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas. Read more about Pancreatic neuroendocrine tumor
19 drugs 18 manufacturers
Drugs that treat it
Common Pancreatic neuroendocrine tumor therapies.
SUNITINIB MALATE
SUNITINIB MALATE
EVEROLIMUS
SUNITINIB MALATE
SUNITINIB MALATE
SUNITINIB MALATE
AFINITOR (everolimus)
EVEROLIMUS
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas.
Although primarily occurring sporadically in adults during their sixth to eighth decades of life, these tumors can also arise in association with hereditary syndromes such as multiple endocrine neoplasia type 1 (MEN1) or von Hippel-Lindau disease.
Pathophysiologically, they are classified as functional or nonfunctional; functional tumors hypersecrete hormones—such as insulin, gastrin, or glucagon—triggering distinct clinical syndromes, whereas nonfunctional tumors manifest through local mass effect or metastatic progression, commonly to the liver.
Biologically, they range from indolent, well-differentiated low-grade tumors to aggressive, poorly differentiated neuroendocrine carcinomas.
- cancer.gov
A pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas Pathophysiologically, they are classified as functional or nonfunctional; functional tumors hypersecrete hormones—such as insulin, gastrin, or glucagon—triggering distinct clinical syndromes, whereas nonfunctional tumors manifest through local mass effect or metastatic progression, commonly to the liver
- uofmhealth.org
A pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas
- cancer.gov
Although primarily occurring sporadically in adults during their sixth to eighth decades of life, these tumors can also arise in association with hereditary syndromes such as multiple endocrine neoplasia type 1 (MEN1) or von Hippel-Lindau disease
- nih.gov
Although primarily occurring sporadically in adults during their sixth to eighth decades of life, these tumors can also arise in association with hereditary syndromes such as multiple endocrine neoplasia type 1 (MEN1) or von Hippel-Lindau disease Biologically, they range from indolent, well-differentiated low-grade tumors to aggressive, poorly differentiated neuroendocrine carcinomas
- nih.gov
Pathophysiologically, they are classified as functional or nonfunctional; functional tumors hypersecrete hormones—such as insulin, gastrin, or glucagon—triggering distinct clinical syndromes, whereas nonfunctional tumors manifest through local mass effect or metastatic progression, commonly to the liver
- pancreatic.org
Biologically, they range from indolent, well-differentiated low-grade tumors to aggressive, poorly differentiated neuroendocrine carcinomas
Personalize your experience
Follow Pancreatic neuroendocrine tumor and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.